| Abbreviation | Full name |
| AD | Alzheimer’s disease |
| PD | Parkinson’s disease |
| ALS | Amyotrophic lateral sclerosis |
| HD | Huntington’s disease |
| FTLD | Frontotemporal lobar dementia |
| BBB | Blood–brain barrier |
| CNS | Central nervous system |
| ROS | Reactive oxygen species |
| TBI | Traumatic brain injury |
| IL-1β | Interleukin-1β |
| TNF-α | Tumor necrosis factor-α |
| IL-10 | Interleukin-10 |
| IL-6 | Interleukin-6 |
| BDNF | Brain-derived neurotrophic factor |
| SCI | Spinal cord injury |
| PI3K | Phosphoinositide 3-kinase |
| AKT | Protein Kinase B |
| MAPK | Mitogen-activated protein kinase |
| Aβ | Amyloid-beta |
| Nrf2 | Nuclear factor-erythroid 2 p45-related factor 2 |
| CAT | Catalase |
| SOD | Superoxide dismutase |
| GPx | Glutathione peroxidase |
| HO-1 | Heme oxygenase-1 |
| NF-κB | Nuclear factor kappa B |
| IκB | Inhibitor of nuclear factor kappa |
| NLRP3 | NLR family pyrin domain containing 3 |
| Keap1 | Kelch-like ECH-associated protein 1 |
| GSK3-β | Glycogen synthase kinase-3 beta |
| GSH | Glutathione |
| OGD/R | Oxygen-glucose deprivation/reoxygenation |
| NMDA | N-methyl d-aspartate |
| AChE | Acetylcholinesterase |
| GABA | Gamma-aminobutyric acid |
| Bcl-2 | B-cell lymphoma 2 |
| MDA | Malondialdehyde |
| TRPC6 | Transient receptor potential canonical 6 channel |
| CREB | Cyclic adenosine monophosphate response element-binding protein (CREB) |
| MEK | Mitogen-activated protein kinase |
| CaMKIV | Calcium/Calmodulin-dependent Protein Kinase IV |
| P2X3 | P2X purinergic receptor 3 |
| P2X2 | P2X purinergic receptor 2 |
| TRPA1 | Transient receptor potential ankyrin 1 |
| NP | Nanoparticle |